29/09/2026
๐ฌ๐ง Mapping Alpha-1 care resources in the ๐จ๐ป๐ถ๐๐ฒ๐ฑ ๐๐ถ๐ป๐ด๐ฑ๐ผ๐บ
The has a network of specialised centres and an active patient community supporting people living with Alpha-1 Antitrypsin Deficiency ( ), while research and clinical trial opportunities continue to evolve.
๐น Access to specialised expertise:
The UK has four specialist Alpha-1 centres located in London, Cambridge, Coventry & Warwickshire, and Birmingham, providing expert diagnosis, multidisciplinary care, and long-term follow-up for people living with Alpha-1.
๐https://alpha1.org.uk/get-support/centres-with-alpha-1-expertise-in-the-uk/
๐น Access to treatment
Augmentation therapy is not currently approved or reimbursed by NICE and NHS England for Alpha-1-related emphysema or COPD. While the UK is rebuilding its domestic plasma medicines programme, Alpha-1 augmentation therapy is not yet included.
๐น Research and European collaboration
The UK participates in the Registry, contributing to European Alpha-1 research. As the clinical trial landscape continues to evolve, patients interested in participating should speak with their Alpha-1 specialist about the most suitable opportunities.
๐ Clinical trial guide: https://alpha1.org.uk/get-support/clinical-trials/
๐น Patient support and awareness
Alpha-1 UK provides information, peer support, patient events, and awareness activities throughout the year, including its annual Alpha-1 Awareness Month campaign in November.
๐ More information: https://alpha1.org.uk/
Together, these resources help strengthen access to specialist care, research opportunities, and patient support for people living with Alpha-1 across the UK.